Loss of reuptake may contribute to a development of (motor complications).
A (monoamine reuptake inhibitor) can be capable of antagonizing (neurotransmitter release).
(Serotonin/norepinephrine reuptake inhibitors) can be selective.
(Serotonin reuptake inhibitor antidepressants) can be selective.
(Serotonin reuptake inhibitors) may block (serotonin reabsorption).